SEC Tracker
Get the app

Replimune Group REPL

Replimune Group discloses insider trading plans

Form
10-Q/A
Filed
Importance
Routine
  1. Philip Astley-Sparke adopted a pre-planned trading plan on Aug 21, 2026 for 488,119 shares
  2. Sushil Patel adopted a pre-planned trading plan on Aug 21, 2026 for 99,665 shares
  3. Konstantinos Xynos adopted a pre-planned trading plan on Aug 20, 2026 for 160,372 shares

Written from the 10-Q/A on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Replimune Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Heron Therapeutics HRTX public float $235M, Jun 30, 2025
  2. Aldeyra Therapeutics ALDX public float $232M, Jun 30, 2025
  3. Sagimet Biosciences SGMT public float $228M, Jun 30, 2025
  4. Annexon ANNX public float $244M, Jun 30, 2025
  5. Lifecore Biomedical LFCR public float $223M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.